nesacaine- chloroprocaine hydrochloride injection, solution
henry schein, inc. - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.
nesacaine- chloroprocaine hydrochloride injection, solution
henry schein, inc. - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.
ampres 50mg/5ml solution for injection ampoules
b.braun medical ltd - chloroprocaine hydrochloride - solution for injection - 10mg/1ml
ampres 10 mg/ml solution for injection
mercury pharmaceuticals ltd - chloroprocaine hydrochloride - solution for injection - 10 mg/ml - esters of aminobenzoic acid
ampres 10mg/ml solution for injection
sintetica uk limited - chloroprocaine hydrochloride - solution for injection - 10 milligram(s)/millilitre - esters of aminobenzoic acid; chloroprocaine
nesacaine ce 3% inj 30mg/ml solution
astrazeneca canada inc - chloroprocaine hydrochloride - solution - 30mg - chloroprocaine hydrochloride 30mg - local anesthetics
ampres 400mg/20ml solution for injection vials
b.braun medical ltd - chloroprocaine hydrochloride - solution for injection - 20mg/1ml
abbott surestep™ multi-drug one step multi-line screen test (urine)
unison collaborative pte. ltd. - clinical toxicology - a rapid, one step screening test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in human urine: amphetamine, cocaine, marijuana (thc), morphine, phencyclidine, benzodiazepines, methadone, opiate, barbiturate, methamphetamine, methylenedioxy-methamphetamine, and tricyclic antidepressants.
abbott surestep™ multi-drug one step screen test (urine)
unison collaborative pte. ltd. - clinical toxicology - a rapid, one step screening test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in human urine: buprenorphine, ketamine, cocaine, cotinine, amphetamine, marijuana (thc), morphine, benzodiazepines, methamphetamine, methylenedioxy-methamphetamine, phencyclidine, tricyclic antidepressants, barbiturates, methadone, and oxycodone.
ampres 10 mg/ml injektionslösung